洋河股份(002304.SZ)擬回購10-15億元的股份 回購價不超135元/股
格隆匯10月29日丨洋河股份(002304.SZ)公佈,公司擬回購10億元-15億元的股份,回購價格不超過135元/股(含),若按回購總金額上限15億元,回購價格上限135元/股進行測算,預計可回購股份數量約1111.1111萬股,佔公司目前總股本比例為0.737%,
回購股份實施期限為自公司第六屆董事會第九次會議審議通過該次回購股份方案之日起12個月內。
回購股份全部用於對核心骨幹員工實施股權激勵或員工持股計劃。公司如在股份回購完成之後36個月內未能實施上述用途,或所回購的股份未全部用於上述用途,未使用的部分將依法予以註銷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.